Icosavax Mourns Sudden Passing of Tadataka Yamada, M.D. Chairman of the Company’s Board of Directors
August 05, 2021 08:00 ET
|
Icosavax, Inc.
SEATTLE, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Icosavax Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 02, 2021 16:01 ET
|
Icosavax, Inc.
SEATTLE, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Monoclonal Antibodies Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2027: Graphical Research
July 22, 2021 06:00 ET
|
Graphical Research
Pune, India, July 22, 2021 (GLOBE NEWSWIRE) -- The global monoclonal antibodies market size is poised to show tremendous growth during the forecast period owing to rise in the percentage of people...
Global Monoclonal Antibodies Market is Expected to Reach $390.58 Billion by 2030: Says AMR
July 20, 2021 08:34 ET
|
Allied Market Research
Portland, OR, July 20, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Monoclonal Antibodies Market was estimated at $146.64 billion in 2020 and is...
Point of Care Testing for Infectious Diseases Market to hit US $2.2 billion by 2025 - Global Insights on Trends, Value Chain Analysis, Regulatory Framework, Drivers, and Future Prospect: Adroit Market Research
May 19, 2021 06:08 ET
|
Adroit Market Research
Dallas, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- The “Global Point of Care Testing for Infectious Diseases Market Size 2019, By Infection Type (HIV, Clostridium difficile, HBV, Pneumonia or...
Infectious Disease POC Diagnostics Market Size 2021 | Is Projected to Reach USD 3,371.1 Million with 17.4% CAGR by 2027
April 27, 2021 06:09 ET
|
Fortune Business Insights
Pune, India, April 27, 2021 (GLOBE NEWSWIRE) -- The global infectious disease POC diagnostics market size is projected to reach USD 3,371.1 million by the end of 2027. The presence of several...
Infectious Disease Diagnostics Market Worth $42.85 billion by 2027- Exclusive Report by Meticulous Research® Covering Emerging Growth Factors, Latest Trends and Forecasts, and Pre and Post COVID-19 Estimates
March 29, 2021 08:44 ET
|
Meticulous Market Research Pvt. Ltd.
London, March 29, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services),...
In-Situ Hybridization Market Size to Reach USD 1,556.6 Million in 2028 | Increasing Technological Advancement and Availability of Diagnostic Solutions will Drive Industry Growth, says Emergen Research
March 23, 2021 10:38 ET
|
Emergen Research
Vancouver, British Columbia, March 23, 2021 (GLOBE NEWSWIRE) -- The global in-situ hybridization market size reached USD 905.3 Million in 2020 and is expected to register a CAGR of 7.1% during the...
In-vitro Diagnostics (IVD) Market to Reach $118.5 Billion by 2027, Growing at a CAGR of 7% from 2020 with the Increasing Demand for Infectious Disease Testing - Meticulous Research® Analysis
March 10, 2021 06:49 ET
|
Meticulous Market Research Pvt. Ltd.
London, March 10, 2021 (GLOBE NEWSWIRE) -- In-vitro diagnostic (IVD) testing has become an indispensable tool in clinical practice for diagnosing and monitoring diseases, providing prognosis, and...
Dyadic Announces Scientific Achievements Reported During ZAPI Stakeholders Virtual Web Meeting
March 09, 2021 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., March 09, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...